Clinical forecasting is now leveraging innovative informatics capabilities for more precise recruitment and endpoint projections during a study’s crucial…


Sanofi nabs long-sought FDA approval for daily GLP-1 contender Adlyxin

With strong Q2, GSK chief Witty sees solid growth platform for his as-yet-unnamed replacement

GSK's vaccines outperform other groups, achieving 11% growth in Q2

GlaxoSmithKline gives U.K. some post-Brexit love with $360M in plant investments

No post-Brexit exit for GSK and AstraZeneca, CEOs will say this week as biopharma rumors swirl

FDA savages GSK plant in warning letter

GSK jumps into Zika vax hunt on heels of Sanofi's deal

New waning efficacy data puts GSK malaria shot's future in question

GSK’s MenABCWY vaccine set to reshape meningococcal space, report says

Public Citizen demands 'black box' warnings on gambling, sex urges for dopamine meds